CD4 and neoplasm: The combination of RT+CpG+OX40 resulted in favorable improvements in the ratio of effector T cells to Tregs in the TME, increased expression of proinflammatory genes in the TME, and activated CD4+ and CD8+ T cells in the tumor draining lymph node (TDLN) and spleen.